Ark Biosciences Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Shanghai China (2014)

Organization Overview

First Clinical Trial
2014
NCT02297594
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ark Biosciences | Ark Biosciences Inc. | Ark Biosciences Pty Ltd. | info@arkbiosciences.com | Shanghai Ark Biopharmaceutical Co., Ltd.